Skip to main content
Equibles

CSS LLC/IL

Position in EXEL — Exelixis, Inc.

CIK 1103646 CHICAGO, IL
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$473,856
-$207,194 QoQ
Shares Held
8,709
-45.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#439
of 756 holders
Holding Since
Jun 2022
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Derivatives in EXEL

reported options exposure · as of Jun 30, 2026
CallValue
$272,050
CallShares
5,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CSS LLC/IL holds $23,787,576 across 16 Biotechnology names. EXEL ranks #7 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 152,289 $12,074,994
2 JAZZ
Jazz Pharmaceuticals plc
 29,041 $6,998,009
3 BMRN
Biomarin Pharmaceutical Inc
 22,580 $1,292,027
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,820 $1,134,842
5 HALO
Halozyme Therapeutics, Inc.
 6,520 $510,320
6 TVTX
Travere Therapeutics, Inc.
 8,470 $481,180
7 EXEL
Exelixis, Inc.
This page 		8,709 $473,856
8 INCY
Incyte Corp
 3,856 $437,116

All Filings in EXEL

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $272,050 5,000
2026-06-30 $473,856 8,709
2026-03-31 $681,050 15,879
2025-12-31 $444,830 10,149
2025-09-30 $394,373 9,549
2022-06-30 $520,500 25,000
2022-06-30 $520,500 25,000